Mary Linton B Peters (Mary Linton Peters)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 19

Top Topics

Squamous Cell Carcinoma

Advanced Non Small Cell Lung Cancer

Respiratory Syndrome Coronavirus

Top Venues

BMJ case reports

Cancer medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Santiago Sucre, Andrea Bullock, Mary Linton B Peters
Efficacy of dual checkpoint inhibitors in a patient with a mixed hepatocellular cholangiocarcinoma. BMJ case reports 17 (5) (2024)
Santiago Sucre, Andrea Bullock, Mary Linton B Peters
Efficacy of dual checkpoint inhibitors in a patient with a mixed hepatocellular cholangiocarcinoma. BMJ case reports 17 (5) (2024)
Santiago Sucre, Andrea Bullock, Mary Linton B Peters
Efficacy of dual checkpoint inhibitors in a patient with a mixed hepatocellular cholangiocarcinoma. BMJ case reports 17 (5) (2024)
Rodrigo Paredes de la Fuente, Santiago Sucre, Cristina Ponce, Ahmed Anwer Ali Rattani, Mary Linton B Peters
Somatic Mutation Profile as a Predictor of Treatment Response and Survival in Unresectable Pancreatic Ductal Adenocarcinoma Treated with FOLFIRINOX and Gemcitabine Nab-Paclitaxel. Cancers 16 (15) (2024)
Santiago Sucre, Andrea Bullock, Mary Linton B Peters
Efficacy of dual checkpoint inhibitors in a patient with a mixed hepatocellular cholangiocarcinoma. BMJ case reports 17 (5) (2024)
Rodrigo Paredes de la Fuente, Santiago Sucre, Cristina Ponce, Ahmed Anwer Ali Rattani, Mary Linton B Peters
Somatic Mutation Profile as a Predictor of Treatment Response and Survival in Unresectable Pancreatic Ductal Adenocarcinoma Treated with FOLFIRINOX and Gemcitabine Nab-Paclitaxel. Cancers 16 (15) (2024)
Rodrigo Paredes de la Fuente, Santiago Sucre, Cristina Ponce, Ahmed Anwer Ali Rattani, Mary Linton B Peters
Somatic Mutation Profile as a Predictor of Treatment Response and Survival in Unresectable Pancreatic Ductal Adenocarcinoma Treated with FOLFIRINOX and Gemcitabine Nab-Paclitaxel. Cancers 16 (15) (2024)
Rodrigo Paredes de la Fuente, James W Doolin, Mary Linton B Peters
Partial response in non-resectable adenosquamous carcinoma of the pancreas with high tumour mutation burden treated with gemcitabine, nab-paclitaxel and pembrolizumab. BMJ case reports 16 (2) (2023)
Mary Linton B Peters, Andrew L Eckel, Claudia L Seguin, Barak Davidi, David H Howard, Amy B Knudsen, Pari V Pandharipande
Cost-Effectiveness Analysis of Screening for Pancreatic Cancer Among High-Risk Populations. JCO oncology practice (2023)
Rodrigo Paredes de la Fuente, James W Doolin, Mary Linton B Peters
Partial response in non-resectable adenosquamous carcinoma of the pancreas with high tumour mutation burden treated with gemcitabine, nab-paclitaxel and pembrolizumab. BMJ case reports 16 (2) (2023)
Leontios Pappas, Islam Baiev, Stephanie Reyes, Andrea Grace Bocobo, Apurva Jain, Kristen Spencer, Tri Minh Le, Osama E Rahma, Jordan Maurer, Jen Stanton, Karen Zhang, Anaemy Danner De Armas, Thomas T Deleon, Marc T Roth, Mary Linton B Peters, Andrew X Zhu, Kylie Boyhen, Christine VanCott, Tushar Patel, Lewis Rowland Roberts, Stacie Lindsey, Nora Horick, Jochen K Lennerz, A John Iafrate, Laura Williams Goff, Kabir Mody, Mitesh J Borad, Rachna T Shroff, Milind M Javle, Robin Kate Kelley, Lipika Goyal
The Cholangiocarcinoma in the Young (CITY) Study: Tumor Biology, Treatment Patterns, and Survival Outcomes in Adolescent Young Adults With Cholangiocarcinoma. JCO precision oncology 7 (2023)
Zachary M Avigan, Rodrigo Paredes, Leora S Boussi, Barbara D Lam, Meghan E Shea, Matthew J Weinstock, Mary Linton B Peters
Updated COVID-19 clearance time among patients with cancer in the Delta and Omicron waves. Cancer medicine (2023)
Rodrigo Paredes de la Fuente, James W Doolin, Mary Linton B Peters
Partial response in non-resectable adenosquamous carcinoma of the pancreas with high tumour mutation burden treated with gemcitabine, nab-paclitaxel and pembrolizumab. BMJ case reports 16 (2) (2023)
Wenxin Xu, Andrew J Piper-Vallillo, Poorva Bindal, Jonathan Wischhusen, Jaymin M Patel, Daniel B Costa, Mary Linton B Peters
Time to SARS-CoV-2 clearance among patients with cancer and COVID-19. Cancer medicine 10 (5) (2021)
Stephanie L Santoro, Mary Linton B Peters
K Awards: The Journey of a Thousand Steps. Annals of internal medicine (2021)
Joseph E Grossman, Lakshmi Muthuswamy, Ling Huang, Dipikaa Akshinthala, Sofia Perea, Raul S Gonzalez, Leo L Tsai, Jonah Cohen, Bruno Bockorny, Andrea J Bullock, Benjamin L Schlechter, Mary Linton B Peters, Catherine Conahan, Supraja Narasimhan, Christine Lim, Roger B Davis, Robert Besaw, Mandeep S Sawhney, Douglas K Pleskow, Tyler M Berzin, Martin Smith, Tara S Kent, Mark Callery, Senthil K Muthuswamy, Manuel Hidalgo
Organoid Sensitivity Correlates with Therapeutic Response in Patients with Pancreatic Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2021)
Wenxin Xu, Andrew J Piper-Vallillo, Poorva Bindal, Jonathan Wischhusen, Jaymin M Patel, Daniel B Costa, Mary Linton B Peters
Time to SARS-CoV-2 Clearance Among Patients with Cancer and COVID-19. medRxiv : the preprint server for health sciences (2020)
Mary Linton B Peters, Lindsey Stobie, Beth Dudley, Eve Karloski, Kyle Allen, Virginia Speare, Jill S Dolinsky, Yuan Tian, Kim DeLeonardis, Jill Krejdovsky, Arlene Button, Cynthia Lim, Erkut Borazanci, Randall Brand, Nadine Tung
Family communication and patient distress after germline genetic testing in individuals with pancreatic ductal adenocarcinoma. Cancer 125 (14) (2019)
Randall Brand, Erkut Borazanci, Virginia Speare, Beth Dudley, Eve Karloski, Mary Linton B Peters, Lindsey Stobie, Nathan Bahary, Herbert Zeh, Amer Zureikat, Melissa Hogg, Kenneth Lee, Allan Tsung, John Rhee, James Ohr, Weijing Sun, James Lee, A James Moser, Kim DeLeonardis, Jill Krejdovsky, Emily Dalton, Holly LaDuca, Jill Dolinsky, Arlene Colvin, Cynthia Lim, Mary Helen Black, Nadine Tung
Prospective study of germline genetic testing in incident cases of pancreatic adenocarcinoma. Cancer 124 (17) (2018)